Protective Effects of Natural Products, Functional Foods, and Probiotics on NSAID-Induced Small Intestinal Injury: A Systematic Review with Mechanistic Considerations of Oxidative Stress and Microbiome Modulation
Abstract
NSAID-induced small intestinal injury is a clinically significant complication among chronic NSAID and aspirin users, yet effective treatment options remain limited. This systematic review evaluated natural products, functional foods, and probiotics for preventing or treating NSAID-induced small intestinal injury. PubMed, Embase, CENTRAL, and CNKI were searched from inception to January 2026 for randomized studies involving adults with NSAID- or aspirin-induced enteropathy assessed using capsule endoscopy or intestinal permeability testing. Risk of bias was assessed using RoB 2 and ROBINS-I. Due to substantial clinical and methodological heterogeneity, meta-analysis was not performed, and findings were synthesized narratively. Twenty-two studies were included: 21 randomized controlled trials and one quasi-randomized study. Geranylgeranylacetone demonstrated protective effects in three of four capsule endoscopy studies. Lactoferrin, zinc carnosine, and fish protein hydrolysate reduced indomethacin-induced intestinal hyperpermeability. Probiotic effects appeared outcome-dependent, with more consistent benefits observed for capsule endoscopy-based mucosal injury outcomes than for intestinal permeability outcomes. Among randomized trials, three were rated as having low risk of bias, 15 had some concerns, and three had high risk. Overall, preliminary evidence suggests that selected natural-origin interventions may protect against NSAID/aspirin-induced small intestinal injury.…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.